Washington Trust Bank Viatris Inc Transaction History

Washington Trust Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$9.2 - $12.26 $607 - $809	-66 Reduced 0.56%	11,819 $113,000
Q4 2022 Feb 06, 2023	SELL	$8.72 - $11.56 $191 - $254	-22 Reduced 0.18%	11,885 $132,000
Q3 2022 Nov 15, 2022	BUY	$8.48 - $11.13 $5,749 - $7,546	678 Added 6.04%	11,907 $101,000
Q2 2022 Aug 04, 2022	SELL	$9.95 - $12.27 $646 - $797	-65 Reduced 0.58%	11,229 $117,000
Q1 2022 May 13, 2022	BUY	$9.81 - $15.4 $110,794 - $173,927	11,294 New	11,294 $123,000

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Washington Trust Bank, based on Form 13F filings with the SEC.

Stay updated on Washington Trust Bank with notifications on news.